Home » Stocks » Nutriband

Nutriband Inc. (NTRB)

Stock Price: $6.02 USD -1.23 (-16.97%)
Updated Oct 26, 2020 12:42 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 36.88M
Revenue (ttm) 305,958
Net Income (ttm) -2.34M
Shares Out 6.13M
EPS (ttm) -0.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $6.02
Previous Close $7.25
Change ($) -1.23
Change (%) -16.97%
Day's Open 6.95
Day's Range 6.02 - 9.00
Day's Volume 605
52-Week Range 6.05 - 29.9

More Stats

Market Cap 36.88M
Enterprise Value 36.98M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 6.13M
Float 3.03M
EPS (basic) -0.43
EPS (diluted) -0.43
FCF / Share -0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -0.64
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 120.54
PB Ratio 34.25
Revenue 305,958
Operating Income -1.32M
Net Income -2.34M
Free Cash Flow -697,554
Net Cash -100,189
Net Cash / Share -0.02
Gross Margin -58.33%
Operating Margin -431.42%
Profit Margin -763.40%
FCF Margin -227.99%
ROA -36.24%
ROE -159.45%
ROIC 231.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $6.02
Target: 24.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth51.11%---
Gross Profit-0.18-0.04--
Operating Income-1.97-3.33-2.67-0.15
Net Income-2.72-3.33-2.67-0.15
Shares Outstanding5.425.354.805.30
Earnings Per Share-0.50-0.62-0.56-0.04
Operating Cash Flow-0.89-1.11-0.09-0.15
Capital Expenditures----
Free Cash Flow-0.89-1.11-0.09-0.15
Cash & Equivalents0.010.47-0.03
Total Debt0.320.040.02-
Net Cash / Debt-0.310.43-0.020.03
Book Value0.182.400.120.02
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nutriband Inc.
Country United States
Employees 3
CEO Gareth R. Sheridan

Stock Information

Ticker Symbol NTRB
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: NTRB


Nutriband develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.